Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Viking Therapeutics
Viking Therapeutics
Why Eli Lilly, Viking Therapeutics, and Novo Nordisk Stocks All Popped Friday
Motley Fool
Sun, 05/4/25 - 12:09 pm
Eli Lilly
Novo Nordisk
Viking Therapeutics
CVS Health
pharma stocks
weight loss
obesity
Will Pfizer Acquire Altimmune or Viking Therapeutics After Its Obesity Pill Setback?
Motley Fool
Wed, 04/30/25 - 11:00 am
Pfizer
obesity
PF-07976016
M&A
Viking Therapeutics
Altimmune
Viking secures 1b supply of obesity pill candidate with $150m prepayment deal
BioSpace
Tue, 03/11/25 - 11:32 am
Viking Therapeutics
obesity
VK2735
Novo, Viking heat up MASH space with promising data at AASLD24
BioSpace
Wed, 11/20/24 - 11:40 am
Novo Nordisk
Viking Therapeutics
MASH
AASLD
GLP-1 agonists
semaglutide
VK2809
Viking data provide latest test of oral obesity drug potential
BioPharma Dive
Mon, 11/4/24 - 06:54 pm
Viking Therapeutics
obesity
clinical trials
Viking Therapeutics Surges, Set To Break Out On Latest Obesity Drug Data
Investors Business Daily
Sun, 11/3/24 - 10:10 pm
Viking Therapeutics
obesity
clinical trials
VK2735
Why Viking Therapeutics Stock Topped the Market Today
Motley Fool
Mon, 09/30/24 - 08:56 pm
Viking Therapeutics
weightloss
VK2735
Weight-loss market to see 16 new drugs by 2029, report estimates
Reuters
Tue, 09/10/24 - 04:29 pm
weight loss
obesity
Amgen
Pfizer
Roche
Novo Nordisk
Eli Lilly
Boehinger Ingelheim
Structure Therapeutics
Viking Therapeutics
Zealand Pharma
Altimmune
Viking shares jump on plans to speed obesity drug into late-stage testing
BioPharma Dive
Thu, 07/25/24 - 11:23 am
Viking Therapeutics
obesity
clinical trials
VK2735
Pfizer's obesity pill news leaves analysts wanting, biotech investors cheering
Fierce Biotech
Fri, 07/12/24 - 11:14 am
Pfizer
obesity
danuglipron
Viking Therapeutics
Terns Pharmaceuticals
Viking's MASH drug scored where Madrigal's didn't, but shares fall on lack of direction
Fierce Biotech
Tue, 06/4/24 - 11:31 pm
Viking Therapeutics
MASH
VK2809
clinical trials vaccines
5 Promising MASH Therapies That Could Follow Madrigal’s Rezdiffra
BioSpace
Mon, 04/15/24 - 11:24 am
MASH
NASH
Madrigal Pharmaceuticals
Rezdiffra
Ionis Pharmaceuticals
ION224
Altimmune
pemvidutid
89Bio
pegozafermin
Viking Therapeutics
VK2809
Aligos Therapeutics
ALG-055009
4 Investigational Weight Loss Drugs That Could Change the Market
BioSpace
Mon, 04/15/24 - 11:09 am
weight loss
Novo Nordisk
CagriSema
Eli Lilly
orforglipro
Viking Therapeutics
VK-2735
Inversago Pharma
INV-202
Viking touts promising phase I data for weight-loss pill candidate
BioSpace
Tue, 03/26/24 - 11:35 am
Viking Therapeutics
clinical trials
obesity
weight loss
VK2735
Could Viking Therapeutics Become the Next Eli Lilly?
Motley Fool
Fri, 03/22/24 - 09:27 am
Viking Therapeutics
Eli Lilly
weight loss
VK-2735
Zepbound
Mounjaro
Should Pfizer Acquire Viking Therapeutics to Take on Eli Lilly and Novo Nordisk in the Obesity Drug Market?
Motley Fool
Fri, 03/15/24 - 11:13 am
Pfizer
obesity
M&A
Viking Therapeutics
Viking Therapeutics' weight-loss drug trial success spurs share surge
Reuters
Tue, 02/27/24 - 11:34 am
Viking Therapeutics
weight loss
clinical trials
2 Rising Biotechs That Could Become the Next Novo Nordisk
Motley Fool
Mon, 01/29/24 - 11:04 am
Novo Nordisk
Madrigal Pharmaceuticals
Viking Therapeutics
NASH
NASH on the Cusp: An Emerging Market Opportunity
BioSpace
Mon, 10/23/23 - 09:53 am
NASH
Viking Therapeutics
Madrigal Pharmaceuticals
Terns Pharmaceuticals
Akero Therapeutics
Hepion Pharmaceuticals
Novo Nordisk
Galmed Pharmaceuticals
3 Biotechs Compete for the Same $108-Billion-Dollar Market
Motley Fool
Wed, 08/23/23 - 10:06 am
NASH
Madrigal Pharmaceuticals
Terns Pharmaceuticals
Viking Therapeutics
Pages
1
2
next ›
last »